Follow The Filings

OLMA Olema Pharmaceuticals Inc.

Health Care, filed as Olema Pharmaceuticals Inc (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.2%
  • $12M

Who owns this now

Largest portfolio weights among holders, up to 0.2% (Stanley Druckenmiller, Duquesne Family Office). Not free-float ownership.

  1. Stanley Druckenmiller 0.24%

Who owns OLMA

Sorted by value, long equity only, as of 2026 Q2.

History
Stanley Druckenmiller, Duquesne Family Office 0.24% Hold 986,827 $12M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by OLMA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All OLMA insider trades
  • None no insider bought on the open market
  • $24.7M sold by 6 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Cyrus Harmon Director
    Sale
    $291K 25,000 shares at $11.65 3.4% of stake
    Traded Jul 23–24 Filed Jul 27
    ↗
  2. Shawnte Mitchell Chief Legal Officer
    Sale
    $952K 40,000 shares at $23.79
    Traded Mar 3–4 Filed Mar 5
    ↗
  3. Cyrus Harmon Director
    Sale
    $269K 10,000 shares at $26.88 1.4% of stake
    Traded Jan 20 Filed Jan 21
    ↗
  4. Cyrus Harmon Director
    Sale
    $102K 3,489 shares at $29.12 0.5% of stake
    Traded Jan 14 Filed Jan 16
    ↗
  5. Shane William Charles Kovacs Ch. Operating & Financial Off.
    Sale
    $3M 103,822 shares at $28.70 43% of stake
    Traded Jan 13–15 Filed Jan 15
    ↗
  6. David C. Myles Ch. Discov. & Non-clin Dev Off
    Sale
    $3.1M 110,000 shares at $28.25
    Traded Jan 12–14 Filed Jan 14
    ↗
  7. Cyrus Harmon Director
    Sale
    $82K 2,881 shares at $28.53 0.4% of stake
    Traded Dec 22, 2025 Filed Dec 29, 2025
    ↗
  8. Naseem Zojwalla Chief Medical Officer
    Sale
    $7.5M 269,509 shares at $27.94 98% of stake
    Traded Dec 19–23 Filed Dec 23, 2025
    ↗
  9. David C. Myles Ch. Discov. & Non-clin Dev Off
    Sale
    $1.6M 51,000 shares at $30.46 8.5% of stake
    Traded Dec 19, 2025 Filed Dec 23, 2025
    ↗
  10. Ian T Clark Director
    Sale
    $7.9M 264,800 shares at $29.73 100% of stake
    Traded Dec 19, 2025 Filed Dec 23, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 13 option exercises, 5 gifts, and 1 stock grant.

SEC filings

Recent issuer filings from EDGAR, 24 shown.

Filed Form Detail Links
SCHEDULE 13D/A — Filing Doc
8-K 5.02 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,2.03 Filing Doc
DEF 14A Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Net income -$96.66M -$129.47M -$162.45M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $266.51M $438.47M $515.45M
Total non-current assets * $10.43M $12.51M $17.98M
Total assets $276.94M $450.98M $533.43M
Total current liabilities $21.62M $41.76M $51.8M
Total non-current liabilities * $1.43M $0.257M $3.07M
Total equity $253.9M $408.96M $478.56M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$83.73M -$104.35M -$146.72M
Cash from investing -$4.85M -$93.53M -$155.76M
Cash from financing $133.42M $268.82M $211.3M
Net change in cash $44.84M $70.94M -$91.18M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.